Drupal.behaviors.print = function(context) {window.print();window.close();}>
Germany's Sygnis Acquires Genetrix's X-Pol Subsidiary Following Qiagen Polymerase Deal
July 19, 2012
Germany's Sygnis Acquires Genetrix's X-Pol Subsidiary Following Qiagen Polymerase Deal
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Qiagen to Distribute Sygnis Pharma Amplification Buffer Under Licensing Pact
May 16, 2013 / PCR Insider
Qiagen Licenses DNA Amplification Technology from Genetrix
July 17, 2012 / GenomeWeb Daily News
Product Watch: Sygnis Pharma's Qualiphi DNA Polymerase; Fluorogenics' Generix Master Mix
April 25, 2013 / PCR Insider
Sygnis Licenses Amplification Buffer to Qiagen
May 16, 2013 / GenomeWeb Daily News
Qiagen Expands Companion Dx Portfolio with Three Licensing Deals; Exceeds 2012 QiaSymphony Placement Target
January 7, 2013 / GenomeWeb Daily News